Kiora Pharmaceuticals (KPRX) has released an update to notify the public and investors about a regulation fd disclosure.
On January 31, 2024, the Company announced an agreement with TOI and scheduled a management presentation for 2:30 p.m. ET the same day. The press release and investor presentation materials were made available, with the latter accessible through the Company’s investor relations website. Additionally, there will be a live webcast and archived recording of the event available online. The provided information, including the exhibits attached to the report, is not considered officially filed under securities law but is intended for use in various meetings with analysts and investors.
For further insights into KPRX stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
